№ files_lp_3_process_7_040975
File format: docx Character count: 7090 File size: 46 KB
Year: 2026
Region / City: Not specified
Topic: Medical treatment, Botox, Urinary incontinence
Document Type: Educational Material, Consent Form
Organization / Institution: Not specified
Author: Not specified
Target Audience: Patients with urinary incontinence
Period of Validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Procedure: Cystoscopy with Botox injection
Anesthesia: Local or general anesthesia
Risks: Allergic reactions, anesthesia complications, flu-like symptoms, infections, muscle weakness, urinary retention, etc.
Alternative Treatments: Medication, device, surgery
Doctor’s Role: Discuss treatment and alternatives
Patient Responsibility: Review and consent to procedure
Side Effects: Temporary results, risks associated with Botox
Pre-treatment Recommendations: Discuss with doctor about medical history, allergies, and medications
Consent: Patient’s signature for approval after understanding risks
Witness: Acknowledgment of patient’s understanding
Physician Confirmation: Physician’s signature confirming the information provided
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
SPT Talks – Chat Summary May 22 – Botox Experiences and Discussions
Year: 2022
Region / City: United States
Topic: Medical treatments for spasticity, Botox use
Document Type: Chat transcript
Organization / Platform: SPT Foundation
Participants: Individuals with neurological conditions (HSP, ALS, PLS)
Treatments Discussed: Botox injections, Baclofen pump, Lorazepam, marijuana use
Healthcare Providers Mentioned: Dr. Mark Courey, Dr. Edward Damrose, neurologists, physiatrists, urologists
Insurance Information: AARP, Medicare, Medicare Advantage, SSDI
Target Audience: Patients managing spasticity or neurological conditions
Related Media: YouTube channel (https://www.youtube.com/channel/UCsZIM577T5rKs8hRjTouczA
Note: )
Medical Terms Defined: Transient Global Amnesia (TGA), CBG, EMG
Dosages Discussed: Botox units for legs and bladder, Baclofen micrograms, Lorazepam milligrams
Patient Experiences: Symptom management, side effects, mobility aids
Regional Stress Urinary Incontinence MDM
Year: 2023
Region / City: New Zealand
Subject: Medical referral for Stress Urinary Incontinence (SUI) treatment
Document Type: Medical Referral Form
Institution: Manatū Hauora (Health Ministry)
Author: Not specified
Target Audience: Healthcare professionals (Referring clinicians, specialists)
Period of Application: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Description: Form for referring patients with stress urinary incontinence for multidisciplinary discussion and evaluation, including medical history, symptoms, diagnostic tests, and treatment options.
Efficacy of a Coin-Sized Tibial Neurostimulator for Urgency Urinary Incontinence: Interim Pivotal Results
Year: 2026
Region / City: United States
Topic: Urgency urinary incontinence treatment
Document Type: Clinical trial report
Institution: Multiple U.S. medical centers
Authors: Alexandra Rogers, MD; Rebecca McCrery, MD; Scott MacDiarmid, MD; Subhro Sen, MD; James Lukban, DO; Bilal Kaaki, MD; Andrew Shapiro, MD; Thomas Giudice, MD; John Nguyen, MD; Joseph Gauta, MD; Scott Serels, MD; Chris Threatt, MD; Jed Kaminetsky, MD; Vincent Lucente, MD; Sonia Dutta, MD; Peter Sand, MD; Kimberly Ferrante, MD
Study Design: Prospective, multi-center, single-arm trial
Participants: 133 adults aged 18-80 with daily UUI episodes
Intervention: Subcutaneous tibial neurostimulator (eCoin) implantation
Primary Outcome: ≥50% improvement in UUI episodes at 48 weeks
Secondary Outcomes: 3-day voiding diary data, patient-reported outcomes
Procedure Time: 20.8 minutes
Safety: One serious device-related adverse event (localized infection resolved by explant)
Incontinence
Year: N/A
Region / City: N/A
Topic: Health, Alzheimer’s disease, Incontinence
Document Type: Informational guide
Organization / Institution: N/A
Author: N/A
Target Audience: Caregivers, healthcare providers, individuals with Alzheimer’s disease
Effective Period: N/A
Approval Date: N/A
Modification Date: N/A
Contextual Description: A guide on managing incontinence in individuals with Alzheimer’s disease, focusing on treatment options and behavioral management strategies for caregivers.
Amendment to Solicitation VA247-16-Q-072006 for Urinary Incontinence Home Telehealth Services, 21 Jun 2016
Year: 2016
Region / City: Birmingham, AL, USA
Topic: Healthcare / Telehealth / Urinary Incontinence
Document Type: Government contract amendment
Issuing Agency: Department of Veterans Affairs, Birmingham VA Medical Center
Contractor: Not specified
Effective Date: 21 Jun 2016
Purpose: Response to vendor questions regarding solicitation requirements and session content
Number of Programs: 5
Session Counts: 21, 28, 79, 79, 56
Target Participants: 250 VA research participants
Reference: FAR 43.103(b)
Method of Acknowledgment: Items 8 and 15 completion, offer copies, or separate letter/telegram
Endorsement: Standard Form 30, GSA prescribed
Subgroup analysis of urinary incontinence types and chemical exposure in adults ≥20 years; NHANES 2007–2016
Year: 2007–2016
Region: United States
Study type: Observational study
Population: Adults aged 20 and older
Health outcomes: Stress, urge, and mixed urinary incontinence
Exposures: Bisphenol A, Triclosan, butylparaben, ethylparaben, methylparaben, propylparaben
Data source: NHANES
Sample size: N=number
Analysis method: Subgroup analysis, odds ratios, 95% confidence intervals
Figures: S2–S7
Topics: onabotulinumtoxinA BOTOX Incontinence